Novozymes A S DKK 2.0
13F holders, Q4 2025 (December 31)3holders +1
1new positions
0sold out
$63.98avg. 13F price*
At the end of Q4 2025, 3 institutions reported holding Novozymes A S DKK 2.0 in their 13F filings, up 1 from Q3 2025. 1 opened new positions and 0 sold out. The largest holders were Somerville Kurt F ($1.1M), Kidder Stephen W ($213K) and Hemenway Trust Co LLC ($204K).
- Company
- Novozymes A S DKK 2.0
- CUSIP
- B798FW902
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $204K |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 3,196 shares bought and 4,400 shares sold, net −1,204 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Somerville Kurt F | 0.18% | Reduce -19.1% | 16,490 | $1.1M |
| Kidder Stephen W | 0.06% | Reduce -13.1% | 3,325 | $213K |
| Hemenway Trust Co LLC | 0.02% | New | 3,196 | $204K |
"% of holder's portfolio" is NOVOZYMES A S DKK 2.0's weight in each manager's 13F, not the share of Novozymes A S DKK 2.0 the manager owns.